• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Cerebral Therapeutics

Cerebral Therapeutics raises $3m for epilepsy drug-device therapy

June 21, 2018 By Sarah Faulkner

Cerebral Therapeutics

Cerebral Therapeutics closed a $3 million Series A financing round this week to support the development of its drug-device therapy designed for patients with refractory epilepsy. The Aurora, Co.-based company’s product uses an implanted, refillable catheter system to deliver a continuous, intracerebroventricular dose of an anti-epileptic drug – valproic acid. Investors that contributed to Cerebral […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Neurological, Pharmaceuticals Tagged With: Cerebral Therapeutics

Fifth patient treated in Flowonix, Cerebral Therapeutics epilepsy study

October 3, 2017 By Sarah Faulkner

Flowonix Medical and Cerebral Therapeutics said today that the fifth patient was successfully treated in its Address trial, which features a micro-infusion device controlling drug delivery to a particular part of the brain in patients with medically refractory epilepsy. The study is the first of its kind, according to the companies. The Address trial is […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Neurological, Pharmaceuticals Tagged With: Cerebral Therapeutics, Flowonix Medical

Medtech stories we missed this week: March 24, 2017

March 24, 2017 By Danielle Kirsh

From companies receiving CE marking to other companies adjusting their distribution deals, here are medtech stories we missed this week but thought were still worth mentioning. 1. Viveve Medical closes public offering Viveve Medical announced that it closed its underwritten public offering of 8,625,00 shares of its common stock, according to a March 22 news release. […]

Filed Under: Clinical Trials, Featured, Orthopedics Tagged With: Astute Medical, Bonesupport, Cerebral Therapeutics, DiamiR, Flowonix, Glaukos, Masimo, Ortho Clinical Diagnostics, Viveve Medical

Prometra micro-infusion device used to deliver meds directly to brain in epilepsy trial

March 15, 2017 By Sarah Faulkner

Flowonix Medical and Cerebral Therapeutics said today that the 1st patients were implanted with the Prometra II programmable infusion system in a clinical trial evaluating the pump in patients with refractory epilepsy. The Address trial marks the 1st time a programmable, implantable pump has been used to deliver medication, in this case valproate, directly to […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Neurological, Wall Street Beat Tagged With: Cerebral Therapeutics, Flowonix Medical

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS